JP2023538260A5 - - Google Patents
Info
- Publication number
- JP2023538260A5 JP2023538260A5 JP2023507600A JP2023507600A JP2023538260A5 JP 2023538260 A5 JP2023538260 A5 JP 2023538260A5 JP 2023507600 A JP2023507600 A JP 2023507600A JP 2023507600 A JP2023507600 A JP 2023507600A JP 2023538260 A5 JP2023538260 A5 JP 2023538260A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- nanoparticles
- approximately
- mol
- nanoparticle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063062367P | 2020-08-06 | 2020-08-06 | |
| US63/062,367 | 2020-08-06 | ||
| PCT/US2021/045038 WO2022032154A2 (en) | 2020-08-06 | 2021-08-06 | Compositions for the delivery of payload molecules to airway epithelium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538260A JP2023538260A (ja) | 2023-09-07 |
| JP2023538260A5 true JP2023538260A5 (https=) | 2024-08-15 |
Family
ID=77543659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507600A Pending JP2023538260A (ja) | 2020-08-06 | 2021-08-06 | ペイロード分子を気道上皮に送達するための組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230285310A1 (https=) |
| EP (1) | EP4192433A2 (https=) |
| JP (1) | JP2023538260A (https=) |
| KR (1) | KR20230087443A (https=) |
| CN (1) | CN116348147A (https=) |
| AU (1) | AU2021320426A1 (https=) |
| BR (1) | BR112023001955A2 (https=) |
| CA (1) | CA3189854A1 (https=) |
| IL (1) | IL300111A (https=) |
| MA (1) | MA71659A (https=) |
| MX (1) | MX2023001461A (https=) |
| TW (1) | TW202214215A (https=) |
| WO (1) | WO2022032154A2 (https=) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL4023249T3 (pl) | 2014-04-23 | 2025-03-10 | Modernatx, Inc. | Szczepionki z kwasem nukleinowym |
| MA42543A (fr) | 2015-07-30 | 2018-06-06 | Modernatx Inc | Arn épitope peptidiques concatémériques |
| AU2016341309A1 (en) | 2015-10-22 | 2018-06-07 | Modernatx, Inc. | Cancer vaccines |
| EP4011451A1 (en) | 2015-10-22 | 2022-06-15 | ModernaTX, Inc. | Metapneumovirus mrna vaccines |
| CA3036831A1 (en) | 2016-09-14 | 2018-03-22 | Modernatx, Inc. | High purity rna compositions and methods for preparation thereof |
| MA46766A (fr) | 2016-11-11 | 2019-09-18 | Modernatx Inc | Vaccin antigrippal |
| US11905525B2 (en) | 2017-04-05 | 2024-02-20 | Modernatx, Inc. | Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins |
| EP3668979A4 (en) | 2017-08-18 | 2021-06-02 | Modernatx, Inc. | METHOD OF HPLC ANALYSIS |
| WO2019036682A1 (en) | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | RNA VARIANTS POLYMERASE |
| EP3746090A4 (en) | 2018-01-29 | 2021-11-17 | ModernaTX, Inc. | RSV RNA Vaccines |
| CA3113025A1 (en) | 2018-09-19 | 2020-03-26 | Modernatx, Inc. | Peg lipids and uses thereof |
| WO2020061295A1 (en) | 2018-09-19 | 2020-03-26 | Modernatx, Inc. | High-purity peg lipids and uses thereof |
| HRP20240586T1 (hr) | 2018-10-09 | 2024-07-19 | The University Of British Columbia | Sastavi i sustavi koji sadrže transfekcijske sposobne vezikle bez organskih otapala i deterdženta i s njim povezanim postupcima |
| CN113874502A (zh) | 2019-03-11 | 2021-12-31 | 摩登纳特斯有限公司 | 补料分批体外转录方法 |
| US12070495B2 (en) | 2019-03-15 | 2024-08-27 | Modernatx, Inc. | HIV RNA vaccines |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| EP4274607A1 (en) | 2021-01-11 | 2023-11-15 | ModernaTX, Inc. | Seasonal rna influenza virus vaccines |
| JP2024511463A (ja) | 2021-03-22 | 2024-03-13 | リコード セラピューティクス，インク． | 細胞への標的送達のための組成物および方法 |
| CA3213107A1 (en) | 2021-03-23 | 2022-09-29 | Mirko HENNIG | Polynucleotide compositions, related formulations, and methods of use thereof |
| US20220363937A1 (en) | 2021-05-14 | 2022-11-17 | Armstrong World Industries, Inc. | Stabilization of antimicrobial coatings |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| WO2023076598A1 (en) * | 2021-10-29 | 2023-05-04 | Modernatx, Inc. | Lipid amines |
| US20250281419A1 (en) * | 2021-10-29 | 2025-09-11 | Modernatx, Inc. | Lipid amines |
| CN118829423A (zh) * | 2021-11-12 | 2024-10-22 | 摩登纳特斯有限公司 | 用于将有效载荷分子递送至气道上皮的组合物 |
| EP4475882A1 (en) | 2022-02-09 | 2024-12-18 | ModernaTX, Inc. | Mucosal administration methods and formulations |
| EP4479082A2 (en) * | 2022-02-15 | 2024-12-25 | The Broad Institute, Inc. | Cell-type specific targeting contractile injection system |
| US20250188028A1 (en) * | 2022-03-14 | 2025-06-12 | Nanovation Therapeutics Inc. | Synthetic Method for Producing Ionizable Amino Lipids |
| EP4509544A4 (en) * | 2022-04-12 | 2025-07-02 | Xiamen Sinopeg Biotech Co Ltd | NONLINEAR PEGYLATED LIPID CONTAINING TERTIARY AMINE AND ITS APPLICATION |
| CN117003808A (zh) * | 2022-04-28 | 2023-11-07 | 北京科兴中维生物技术有限公司 | 一种阳离子脂质化合物及其制备方法和用途 |
| CN119816292A (zh) * | 2022-08-08 | 2025-04-11 | 先进核糖核酸疫苗(Arv)技术股份有限公司 | 基于甾醇的可电离脂质以及包含其的脂质纳米颗粒 |
| IL320459A (en) | 2022-10-27 | 2025-06-01 | Pfizer | Rna molecules encoding rsv-f and vaccines containing them |
| US20250367129A1 (en) | 2022-11-04 | 2025-12-04 | Pfizer Inc. | Lipid Compounds and Uses Thereof |
| EP4630057A1 (en) | 2022-12-08 | 2025-10-15 | Recode Therapeutics, Inc. | Lipid nanoparticle compositions and uses thereof |
| AU2023409158A1 (en) * | 2022-12-19 | 2025-07-03 | Fujifilm Corporation | Methods of delivering therapeutic agents, and lipid compositions |
| EP4658636A1 (en) | 2023-01-31 | 2025-12-10 | Pfizer Inc. | Lipid compounds and uses thereof |
| CN121263425A (zh) * | 2023-02-13 | 2026-01-02 | 旗舰创业创新第七有限责任公司 | 含可裂解接头的可电离脂质和用于治疗性组合物的脂质载体 |
| CN121487722A (zh) * | 2023-04-14 | 2026-02-06 | 北京剂泰生命科技有限公司 | 靶向脾的脂质纳米颗粒 |
| EP4704905A1 (en) * | 2023-05-02 | 2026-03-11 | Sage Therapeutics, LLC | Lymphatic system-targeting compounds |
| EP4704816A1 (en) * | 2023-05-03 | 2026-03-11 | ModernaTX, Inc. | Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis |
| WO2025027492A1 (en) | 2023-07-31 | 2025-02-06 | Pfizer Inc. | Coronavirus antigen variants |
| WO2025034764A1 (en) * | 2023-08-07 | 2025-02-13 | Life Technologies Corporation | Lipids for delivery of nucleic acids to eukaryotic cells |
| US12364773B2 (en) | 2023-12-01 | 2025-07-22 | Recode Therapeutics, Inc. | Lipid nanoparticle compositions and uses thereof |
| WO2025126019A1 (en) | 2023-12-13 | 2025-06-19 | Pfizer Inc. | Rna molecules |
| WO2025126071A1 (en) | 2023-12-14 | 2025-06-19 | Pfizer Inc. | Rna molecules |
| WO2025126113A1 (en) | 2023-12-15 | 2025-06-19 | Pfizer Inc. | Lipid compounds and uses thereof |
| WO2025126118A1 (en) | 2023-12-15 | 2025-06-19 | Pfizer Inc. | Lipid compounds and uses thereof |
| CN121015605A (zh) * | 2024-01-19 | 2025-11-28 | 晟迪生物医药(苏州)有限公司 | 含有可电离脂质的肺部递送系统、其制备方法和应用 |
| WO2025180480A1 (zh) * | 2024-03-01 | 2025-09-04 | 北京剂泰医药科技有限公司 | 靶向肌肉的脂质纳米颗粒 |
| WO2025186725A2 (en) | 2024-03-06 | 2025-09-12 | Pfizer Inc. | Improved lnp formulations and uses thereof |
| WO2025207803A1 (en) * | 2024-03-26 | 2025-10-02 | General Therapeutics, Inc. | Lipid compounds, compositions and methods of use thereof |
| CN120718086A (zh) * | 2024-06-13 | 2025-09-30 | 仁景(苏州)生物科技有限公司 | 用于递送的脂质化合物和脂质纳米颗粒 |
| WO2026018181A1 (en) | 2024-07-17 | 2026-01-22 | Pfizer Inc. | Immunogenic compositions and uses thereof |
| WO2026029597A1 (ko) * | 2024-07-31 | 2026-02-05 | 주식회사 메디치바이오 | 신규한 스테롤 지질 또는 이의 유도체를 함유하는 지질 나노입자 조성물 |
| WO2026030275A1 (en) | 2024-08-01 | 2026-02-05 | Pfizer Inc. | Rna molecules |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681702A (en) | 1994-08-30 | 1997-10-28 | Chiron Corporation | Reduction of nonspecific hybridization by using novel base-pairing schemes |
| US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| US5840710A (en) * | 1994-12-09 | 1998-11-24 | Genzyme Corporation | Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules |
| US5925628A (en) * | 1997-03-31 | 1999-07-20 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| US5942634A (en) * | 1997-05-09 | 1999-08-24 | Genzyme Corporation | Cationic amphiphiles for cell transfections |
| US20030073640A1 (en) | 1997-07-23 | 2003-04-17 | Ribozyme Pharmaceuticals, Inc. | Novel compositions for the delivery of negatively charged molecules |
| US7404969B2 (en) | 2005-02-14 | 2008-07-29 | Sirna Therapeutics, Inc. | Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| WO2007086881A2 (en) | 2005-02-14 | 2007-08-02 | Sirna Therapeutics, Inc. | Cationic lipids and formulated molecular compositions containing them |
| CA2689042A1 (en) | 2007-02-16 | 2008-08-28 | Merck & Co., Inc. | Compositions and methods for potentiated activity of biologicaly active molecules |
| EP2217221B1 (en) * | 2007-10-17 | 2018-06-27 | Korea Advanced Institute of Science and Technology | Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same |
| WO2010021865A1 (en) | 2008-08-18 | 2010-02-25 | Merck Sharp & Dohme Corp. | Novel lipid nanoparticles and novel components for delivery of nucleic acids |
| WO2010080724A1 (en) | 2009-01-12 | 2010-07-15 | Merck Sharp & Dohme Corp. | Novel lipid nanoparticles and novel components for delivery of nucleic acids |
| US8569256B2 (en) | 2009-07-01 | 2013-10-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| WO2011000107A1 (en) | 2009-07-01 | 2011-01-06 | Protiva Biotherapeutics, Inc. | Novel lipid formulations for delivery of therapeutic agents to solid tumors |
| ES2579936T3 (es) | 2009-08-20 | 2016-08-17 | Sirna Therapeutics, Inc. | Nuevos lípidos catiónicos con diversos grupos de cabeza para el suministro oligonucleotídico |
| EP2485770A4 (en) | 2009-10-08 | 2013-04-10 | Merck Sharp & Dohme | Novel cationic lipids with short lipid chains for oligonucleotide delivery |
| EP3318248B1 (en) | 2009-12-01 | 2019-04-10 | Translate Bio, Inc. | Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases |
| EP2525781A1 (en) | 2010-01-22 | 2012-11-28 | Schering Corporation | Novel cationic lipids for oligonucleotide delivery |
| WO2011143230A1 (en) | 2010-05-10 | 2011-11-17 | Alnylam Pharmaceuticals | Methods and compositions for delivery of active agents |
| US20130123338A1 (en) | 2010-05-12 | 2013-05-16 | Protiva Biotherapeutics, Inc. | Novel cationic lipids and methods of use thereof |
| US8802863B2 (en) | 2010-05-24 | 2014-08-12 | Sirna Therapeutics, Inc. | Amino alcohol cationic lipids for oligonucleotide delivery |
| DK2575767T3 (en) | 2010-06-04 | 2017-03-13 | Sirna Therapeutics Inc | HOWEVER UNKNOWN LOW MOLECULAR CATIONIC LIPIDS TO PROCESS OIGONUCLEOTIDES |
| US8466122B2 (en) | 2010-09-17 | 2013-06-18 | Protiva Biotherapeutics, Inc. | Trialkyl cationic lipids and methods of use thereof |
| CA2809858C (en) | 2010-09-20 | 2019-11-12 | Sirna Therapeutics, Inc. | Novel low molecular weight cationic lipids for oligonucleotide delivery |
| CA2811430A1 (en) | 2010-09-30 | 2012-04-05 | Merck Sharp & Dohme Corp. | Low molecular weight cationic lipids for oligonucleotide delivery |
| EP2625189B1 (en) | 2010-10-01 | 2018-06-27 | ModernaTX, Inc. | Engineered nucleic acids and methods of use thereof |
| EP3485913A1 (en) | 2010-10-21 | 2019-05-22 | Sirna Therapeutics, Inc. | Low molecular weight cationic lipids for oligonucleotide delivery |
| WO2012061259A2 (en) | 2010-11-05 | 2012-05-10 | Merck Sharp & Dohme Corp. | Novel low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery |
| CA2824526C (en) | 2011-01-11 | 2020-07-07 | Alnylam Pharmaceuticals, Inc. | Pegylated lipids and their use for drug delivery |
| ES2795110T3 (es) | 2011-06-08 | 2020-11-20 | Translate Bio Inc | Lípidos escindibles |
| US9126966B2 (en) | 2011-08-31 | 2015-09-08 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods of use thereof |
| WO2013086373A1 (en) | 2011-12-07 | 2013-06-13 | Alnylam Pharmaceuticals, Inc. | Lipids for the delivery of active agents |
| WO2013086354A1 (en) | 2011-12-07 | 2013-06-13 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
| WO2013103659A1 (en) | 2012-01-04 | 2013-07-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus |
| WO2013116126A1 (en) | 2012-02-01 | 2013-08-08 | Merck Sharp & Dohme Corp. | Novel low molecular weight, biodegradable cationic lipids for oligonucleotide delivery |
| EP2817287B1 (en) | 2012-02-24 | 2018-10-03 | Arbutus Biopharma Corporation | Trialkyl cationic lipids and methods of use thereof |
| WO2014093924A1 (en) | 2012-12-13 | 2014-06-19 | Moderna Therapeutics, Inc. | Modified nucleic acid molecules and uses thereof |
| KR20140048404A (ko) * | 2012-10-11 | 2014-04-24 | 포항공과대학교 산학협력단 | 저밀도 지단백질 유사 나노입자 및 이를 포함하는 간 표적 진단 및 치료용 조성물 |
| PL2922554T3 (pl) | 2012-11-26 | 2022-06-20 | Modernatx, Inc. | Na zmodyfikowany na końcach |
| US20160022840A1 (en) | 2013-03-09 | 2016-01-28 | Moderna Therapeutics, Inc. | Heterologous untranslated regions for mrna |
| EP2968391A1 (en) | 2013-03-13 | 2016-01-20 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| CN105143456A (zh) | 2013-03-15 | 2015-12-09 | 不列颠哥伦比亚大学 | 用于转染的脂质纳米粒子和相关方法 |
| HUE060907T2 (hu) | 2014-06-25 | 2023-04-28 | Acuitas Therapeutics Inc | Új lipidek és lipid nanorészecske formulációk nukleinsavak bevitelére |
| HRP20230209T1 (hr) | 2015-10-28 | 2023-04-14 | Acuitas Therapeutics Inc. | Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina |
| EP4186888B1 (en) * | 2017-03-15 | 2025-11-26 | ModernaTX, Inc. | Compound and compositions for intracellular delivery of therapeutic agents |
| CA3055653A1 (en) * | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Lipid nanoparticle formulation |
| US11529314B2 (en) * | 2017-11-10 | 2022-12-20 | Board Of Regents, The University Of Texas System | Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents |
| CN118697900A (zh) | 2019-01-31 | 2024-09-27 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
-
2021
- 2021-08-06 MA MA71659A patent/MA71659A/fr unknown
- 2021-08-06 CA CA3189854A patent/CA3189854A1/en active Pending
- 2021-08-06 AU AU2021320426A patent/AU2021320426A1/en not_active Abandoned
- 2021-08-06 US US18/040,485 patent/US20230285310A1/en active Pending
- 2021-08-06 KR KR1020237007762A patent/KR20230087443A/ko not_active Withdrawn
- 2021-08-06 CN CN202180068470.XA patent/CN116348147A/zh active Pending
- 2021-08-06 MX MX2023001461A patent/MX2023001461A/es unknown
- 2021-08-06 EP EP21762908.8A patent/EP4192433A2/en active Pending
- 2021-08-06 BR BR112023001955A patent/BR112023001955A2/pt not_active Application Discontinuation
- 2021-08-06 JP JP2023507600A patent/JP2023538260A/ja active Pending
- 2021-08-06 IL IL300111A patent/IL300111A/en unknown
- 2021-08-06 WO PCT/US2021/045038 patent/WO2022032154A2/en not_active Ceased
- 2021-08-06 TW TW110129202A patent/TW202214215A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538260A5 (https=) | ||
| JP2024545584A5 (https=) | ||
| AU2013351934B2 (en) | Prostacylin compositions and methods for using the same | |
| US10081598B2 (en) | Cationic lipid | |
| US6124270A (en) | Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug | |
| KR101476167B1 (ko) | 약물 송달 제어용 경폐 투여 리포좀 | |
| US9233971B2 (en) | Lipomacrocycles and uses thereof | |
| JP7708388B2 (ja) | 荷電物質を送達する脂質、その製剤、およびその製造方法 | |
| JP2024527940A5 (https=) | ||
| CN107260679B (zh) | 用以减少眼用类固醇的并发症的药物组合物 | |
| CN118319880B (zh) | 靶向肺部高效递送核酸的脂质纳米颗粒、吸入式制剂及应用 | |
| JP7832717B2 (ja) | 硫化物を含むイオン化可能な脂質、及びこれを含む脂質ナノ粒子 | |
| WO2024094194A1 (zh) | 一种用于雾化吸入脂质纳米粒的通用型处方 | |
| WO2023246218A1 (zh) | 用于核酸递送的可电离脂质及其组合物 | |
| JP2024545584A (ja) | ペイロード分子を気道上皮に送達するための組成物 | |
| EP4628496A1 (en) | Steroid-cationic lipid compound and use thereof | |
| CN117946201B (zh) | 脂质化合物和脂质纳米颗粒组合物 | |
| WO2024019770A1 (en) | Methods of making ionizable lipids and lipid nanoparticles for mrna delivery | |
| TW202530174A (zh) | 用於遞送的脂質化合物及脂質奈米顆粒 | |
| EP4626858A1 (en) | Novel ionizable lipids and lipid nanoparticles comprising the same | |
| CN118164866A (zh) | 阳离子脂质化合物及其组合物和应用 | |
| WO2024017254A1 (zh) | 氨基脂质化合物、其制备方法和应用 | |
| WO2022259958A1 (ja) | リン脂質 | |
| NZ820531B2 (en) | Long-acting spleen-targeting cationic lipid compound comprising benzene ring structure, composition comprising same, and use thereof | |
| NZ820531A (en) | Long-acting spleen-targeting cationic lipid compound comprising benzene ring structure, composition comprising same, and use thereof |